Catherine L. Gallagher, MD Print Friendly Page
Faculty, University of Wisconsin School of Medicine and Public HealthDr. Gallagher is an Associate professor of Neurology (CHS) at the University of Wisconsin School of Medicine and Public Health. She is also a staff physician at the Middleton VA Hospital. She specializes in movement disorders with special interests in young onset Parkinson’s disease, atypical Parkinsonian syndromes and normal pressure hydrocephalus (NPH). She performs botulinum toxin injections with electromyographic guidance and diagnostic electromyographic studies at the VA.
Specialties
UW Health Clinics
Hospital Affiliation(s)
Languages Spoken
| English |
| Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000. |
UW School of Medicine and Public Health
| Department of Neurology |
Professional Certifications and Education
| Board Certification |
Neurology
|
| Residency |
University of Wisconsin Hospital and Clinics, Madison, WI
|
| Internship |
University of Wisconsin Hospital and Clinics, Madison, WI
|
| Medical School |
University of Colorado, Denver, 1993
|
Procedures
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
- Lumbar Puncture
| Research |
Dr. Gallagher has initiated research projects in normal pressure hydrocephalus (NPH) and Parkinson’s disease. Her most significant focus is in the correlation between positron emission tomography images and symptoms of Parkinson’s disease. She has recently received a career development grant from the Veterans Administration that will focus on Parkinson’s disease. At the University of Wisconsin School of Medicine and Public Health, Dr. Gallagher is an educator of medical students, residents and fellows. She is the former director of the Integrated Clinical Neurosciences course for senior medical students and has received several awards for her teaching accomplishments. |
PubMed Articles
-
Gallagher C Bell B Bendlin B Palotti M Okonkwo O Sodhi A Wong R Buyan-Dent L Johnson S Wilette A Harding S Ninman N Kastman E Alexander A .
White matter microstructural integrity and executive function in Parkinson's disease. J Int Neuropsychol Soc. 2013 Mar;19(3):349-54
[PubMed ID: 23321049]
-
Okonkwo OC Xu G Oh JM Dowling NM Carlsson CM Gallagher CL Birdsill AC Palotti M Wharton W Hermann BP Larue A Bendlin BB Rowley HA Asthana S Sager MA Johnson SC .
Cerebral Blood Flow is Diminished in Asymptomatic Middle-Aged Adults with Maternal History of Alzheimer's Disease. Cereb Cortex. 2012 Dec 12;
[PubMed ID: 23236200]
-
Willette AA Gallagher C Bendlin BB McLaren DG Kastman EK Canu E Kosmatka KJ Field AS Alexander AL Colman RJ Voytko ML Weindruch RH Coe CL Johnson SC .
Homocysteine, neural atrophy, and the effect of caloric restriction in rhesus monkeys. Neurobiol Aging. 2012 Apr;33(4):670-80
[PubMed ID: 20691506]
-
Struck AF Hall LT Kusmirek JE Gallagher CL Floberg JM Jaskowiak CJ Perlman SB .
(18)F-DOPA PET with and without MRI fusion, a receiver operator characteristics comparison. Am J Nucl Med Mol Imaging. 2012;2(4):475-82
[PubMed ID: 23145363]
-
Gallagher CL Johnson SC Bendlin BB Chung MK Holden JE Oakes TR Brooks BR Konopacki RA Dogan S Abbs JH Xu G Nickles RJ Pyzalski RW Dejesus OT Brown WD .
A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's disease. Brain Imaging Behav. 2011 Sep;5(3):203-11
[PubMed ID: 21556744]
-
Gallagher CL Christian BT Holden JE Dejesus OT Nickles RJ Buyan-Dent L Bendlin BB Harding SJ Stone CK Mueller B Johnson SC .
A within-subject comparison of 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa in Parkinson's disease. Mov Disord. 2011 Sep;26(11):2032-8
[PubMed ID: 21638324]
-
Gallagher CL Oakes TR Johnson SC Chung MK Holden JE Bendlin BB McLaren DG Xu G Nickles RJ Pyzalski R DeJesus O Brown WD .
Rate of 6-[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease. Mov Disord. 2011 Mar;26(4):614-20
[PubMed ID: 21449008]
-
Bendlin BB Newman LM Ries ML Puglielli L Carlsson CM Sager MA Rowley HA Gallagher CL Willette AA Alexander AL Asthana S Johnson SC .
NSAIDs may protect against age-related brain atrophy. Front Aging Neurosci. 2010 Sep 3;2
[PubMed ID: 20877426]
-
Ward MA Bendlin BB McLaren DG Hess TM Gallagher CL Kastman EK Rowley HA Asthana S Carlsson CM Sager MA Johnson SC .
Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults. Front Aging Neurosci. 2010 Jul 15;2
[PubMed ID: 20725527]
-
Bordini BJ Garg A Gallagher CL Bell B Garell PC .
Neuropsychological effects of bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Stereotact Funct Neurosurg. 2007;85(2-3):113-20
[PubMed ID: 17228177]
-
Gallagher CL Garell PC Montgomery EB Jr .
Hemi tics and deep brain stimulation. Neurology. 2006 Feb 14;66(3):E12
[PubMed ID: 16476922]
-
Kawakami N Jessen H Bordini B Gallagher C Klootwyk J Garell CP .
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease. WMJ. 2005 Aug;104(6):35-8
[PubMed ID: 16218314]
-
Gallagher CL Waclawik AJ Beinlich BR Harding CO Pauli RM Poirer J Pandolfo M Salamat MS .
Friedreich's ataxia associated with mitochondrial myopathy: clinicopathologic report. J Child Neurol. 2002 Jun;17(6):453-6
[PubMed ID: 12174969]
